Skip to main content

Polyp and Adenoma Detection During Colonoscopy

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Cosmo Pharmaceuticals
Cosmo PharmaceuticalsIreland - Dublin
1 program
oral tablet dye for detection of polyps during colonoscopyN/A1 trial
Active Trials
NCT01520337Completed170Est. Oct 2013

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Cosmo Pharmaceuticalsoral tablet dye for detection of polyps during colonoscopy

Clinical Trials (1)

Total enrollment: 170 patients across 1 trials

NCT01520337Cosmo Pharmaceuticalsoral tablet dye for detection of polyps during colonoscopy

Polyp Detection Rate After Single Oral Dose of Methylene Blue MMX Modified Release Tablets Administered to Subjects Undergoing Outpatients Colonoscopy

Start: Jan 2012Est. completion: Oct 2013170 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.